eletriptan
(UTINOWOSWSPFLJ-FSRHSHDFSA-N)
Structure
- SMILES
- CN1CCC[C@@H]1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1.Br
- Molecular Formula:
- C22H27BrN2O2S
- Molecular Weight:
- 463.431
- Log P:
- 5.7978
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 2
- TPSA:
- 61.55
- CAS Number(s):
- 177834-92-3
Synonym(s)
1.
eletriptan
2.
(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole
3.
(R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide
4.
3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide
5.
Relpax
6.
UK 166,044
7.
UK 166044
8.
UK-116,044-04
9.
UK-116044-04
10.
UK-166,044
11.
UK-166044
12.
eletriptan hydrobromide
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 57 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Pain | FAERS: 5 | US FAERS | |
| 4 | Malaise | FAERS: 4 | US FAERS | |
| 5 | Feeling abnormal | FAERS: 3 | US FAERS | |
| 6 | Somnolence | FAERS: 3 | US FAERS | |
| 7 | Vomiting | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Dizziness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Drug effect delayed | FAERS: 2 | US FAERS | |
| 10 | Frustration tolerance decreased | FAERS: 2 | US FAERS | |
| 11 | Headache | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Product substitution issue | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 13 | Therapeutic product effect incomplete | FAERS: 2 | US FAERS | |
| 14 | Accidental overdose | FAERS: 1 | US FAERS | |
| 15 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 16 | Anxiety | FAERS: 1 | US FAERS | |
| 17 | Arthralgia | FAERS: 1 | US FAERS | |
| 18 | Asthenia | FAERS: 1 | US FAERS | |
| 19 | Back Pain | FAERS: 1 | US FAERS | |
| 20 | Burning sensation | FAERS: 1 | US FAERS | |
| 21 | Chest Pain | FAERS: 1 | US FAERS | |
| 22 | Chest discomfort | FAERS: 1 | US FAERS | |
| 23 | Crying | FAERS: 1 | US FAERS | |
| 24 | Epistaxis | FAERS: 1 | US FAERS | |
| 25 | Fatigue | FAERS: 1 | US FAERS | |
| 26 | Flushing | FAERS: 1 | US FAERS | |
| 27 | Insurance issue | FAERS: 1 | US FAERS | |
| 28 | Limb discomfort | FAERS: 1 | US FAERS | |
| 29 | Medication Error | FAERS: 1 | US FAERS | |
| 30 | Overdose | FAERS: 1 | US FAERS | |
| 31 | Photophobia | FAERS: 1 | US FAERS | |
| 32 | Posterior reversible encephalopathy syndrome | FAERS: 1 | US FAERS | |
| 33 | Product dispensing error | FAERS: 1 | US FAERS | |
| 34 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 35 | Product packaging issue | FAERS: 1 | US FAERS | |
| 36 | Reaction to excipient | FAERS: 1 | US FAERS | |
| 37 | Sinus bradycardia | FAERS: 1 | US FAERS | |
| 38 | Therapeutic product effect delayed | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 39 | Therapeutic response changed | FAERS: 1 | US FAERS | |
| 40 | Wheezing | FAERS: 1 | US FAERS | |
| 41 | treatment failure | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Drug Dependence | Canada Vigilance: 1 | Canada Vigilance | |
| 43 | Loss of personal independence in daily activities | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.